Drug safety check: how does a damaged liver handle this medicine?
NCT ID NCT05607173
Summary
This study aimed to understand how liver problems affect the way the body processes the drug fexinidazole. It involved 21 adults, some with mild or moderate liver impairment and others with normal liver function, who each took a single dose. Researchers measured the drug levels in their blood to see if liver impairment changes how much drug stays in the body, which is important for future safe use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FUNCTION ABNORMAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number: 100-0001
Sofia, 1612, Bulgaria
-
Investigational site 250-0001
Rennes, France
Conditions
Explore the condition pages connected to this study.